Vella Bioscience News Today

/PRNewswire/ -- Vella Bioscience, a biotech startup in service of female sexual empowerment, is today announcing the Consortium for the Study of Womens Sexual...

Women in Sheffield reported enjoying the longest orgasms in the UK as well as a high frequency of orgasms, at 60 per cent of times from sex with a partner, it reveals.

/PRNewswire/ -- The board of Vella Bioscience, a womans sexual wellness brand, announces the appointment of Carolyn Wheeler to the position of CEO, and Nial...

/PRNewswire/ -- Vella Bioscience Inc. whose Womens Pleasure Serum has been dubbed the "Womens Viagra®," has announced today that the Patent and Trademark...

The sexual wellness category on the website features a few dozen devices and products.

To sleep naked, or not to sleep naked? Experts weigh in on whether sleeping in the nude actually helps you sleep better, and other health pros and cons to consider.

The round, anchored by Aaron Fleck & Associates, was raised at over $50m post-money valuation. The company intends to use the funds to advance a product portfolio of science-driven innovations, further strengthening the promise of sexual empowerment for all women. Led by Chief Executive Officer Nial DeMena, and Chief Operating Officer Carolyn Vella, Vella Bioscience provides Pleasure Serum, a clinically demonstrated pre-play topical serum that promotes increased arousal and lubrication, ...

Share this article Share this article LOS ANGELES, May 3, 2021 /PRNewswire/ -- Vella Bioscience, Inc. today announced its formation as a femtech company driven to put science in service of every womans sexual empowerment. The company launches with its breakthrough flagship product – Vella Womens Pleasure Serum, a first-of-its-kind pre-play topical serum to promote more frequent, intense, and satisfying orgasms for every cis woman – whether solo or with a partner.  Founded by a team of me...